Clinical trial
Combination Chemotherapy in Treating Children With Lymphoma
NCT00002590 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00002590 |
|---|---|
| Title | Combination Chemotherapy in Treating Children With Lymphoma |
| Official title | A Pilot Study For The Treatment of Newly-Diagnosed Disseminated Anaplastic Large Cell Ki-1 Lymphoma and T-Large Cell Lymphoma |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug, Radiation |
| Interventions | filgrastim, cyclophosphamide, cytarabine, daunorubicin hydrochloride, doxorubicin hydrochloride, etoposide, leucovorin calcium, methotrexate, pegaspargase, prednisone and 3 more |
| Enrollment | 221 |
| Start date | Jul 1, 1994 |
| Primary completion | Mar 1, 2001 |
| Completion | Mar 1, 2007 |
| First posted | Apr 29, 2004 |
| Last update posted | Jul 24, 2014 |
| Countries | Australia, Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: